Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental basis for hepatic cryotherapy

B A Mascarenhas1, T S Ravikumar

  • 1Department of Surgery, Cancer Institute of New Jersey, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick 08901, USA.

Seminars in Surgical Oncology
|March 11, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nimbolide attenuates hepatocellular carcinoma by regulating miRNAs 21, 145 and 221 and their target gene expression.

Gene·2024
Same author

Candesartan cilexetil ameliorates NOSTRIN-NO dependent portal hypertension in cirrhosis and ACLF.

European journal of pharmacology·2023
Same author

Investigations of an organic-inorganic nanotheranostic hybrid for pancreatic cancer therapy using cancer-in-a-dish and<i>in vivo</i>models.

Biomedical materials (Bristol, England)·2022
Same author

Development and evaluation of a multi-functional organic-inorganic nanotheranostic hybrid for pancreatic cancer therapy.

Biomedical materials (Bristol, England)·2021
Same author

Decreasing medication errors in four intensive care units of a tertiary care teaching hospital in India using a sensitization programme.

The National medical journal of India·2020
Same author

Dataset for compression ignition engine fuelled with corn oil methyl ester biodiesel.

Data in brief·2019
Same journal

Preoperative chemoradiation for locally advanced rectal cancer: rationale, technique, and results of treatment.

Seminars in surgical oncology·2003
Same journal

Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience.

Seminars in surgical oncology·2003
Same journal

Postoperative adjuvant therapy for pancreatic cancer.

Seminars in surgical oncology·2003
Same journal

Conformal chemoradiation for primary and metastatic liver malignancies.

Seminars in surgical oncology·2003
Same journal

Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.

Seminars in surgical oncology·2003
Same journal

Combined modality therapy in esophageal cancer: the Memorial experience.

Seminars in surgical oncology·2003
See all related articles

Hepatic cryotherapy offers a safe and effective treatment for liver tumors. Technological advancements are improving delivery, and combining it with other therapies may enhance success rates.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Interventional Radiology

Background:

  • Hepatic cryotherapy is a minimally invasive treatment for liver tumors.
  • Primary and secondary liver tumors are significant clinical challenges.
  • Evaluating safety and efficacy is crucial for therapeutic adoption.

Purpose of the Study:

  • To review the experimental basis for hepatic cryotherapy in liver tumors.
  • To assess the safety and efficacy of this therapeutic modality.
  • To discuss technological advancements and future directions.

Main Methods:

  • Review of experimental data on hepatic cryotherapy in liver tumor treatment.
  • Analysis of animal studies demonstrating technique effectiveness.
  • Evaluation of technological improvements in cryotherapy delivery systems.

Related Experiment Videos

Main Results:

  • Hepatic cryotherapy shows promise as a treatment for primary and secondary liver tumors.
  • Animal studies confirm the effectiveness of cryotherapy for liver tumors.
  • Technological innovations have enhanced the precision and delivery of hepatic cryotherapy.

Conclusions:

  • Hepatic cryotherapy is a viable option for liver tumor treatment.
  • Ongoing technological advancements are improving its application.
  • Combination therapy with hepatic cryotherapy may improve treatment outcomes.